Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
Status:
Completed
Trial end date:
2016-05-19
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to evaluate the efficacy of GWP42003-P as adjunctive
treatment in reducing the number of drop seizures when compared with placebo in participants
with Lennox-Gastaut syndrome (LGS).